Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 522Neoplasms 470Carcinoma, Non-Small-Cell Lung 393Prostatic Neoplasms 302Colorectal Neoplasms 296Lung Neoplasms 259Neoplasm Metastasis 217Ovarian Neoplasms 198Leukemia, Myeloid, Acute 194Pancreatic Neoplasms 185Multiple Myeloma 172Squamous Cell Carcinoma of Head and Neck 133Recurrence 132Stomach Neoplasms 129Brain Neoplasms 126Melanoma 123Carcinoma, Hepatocellular 123Endometrial Neoplasms 120Glioblastoma 118Triple Negative Breast Neoplasms 111Precursor Cell Lymphoblastic Leukemia-Lymphoma 105Hematologic Neoplasms 99Head and Neck Neoplasms 97Carcinoma, Renal Cell 96Lymphoma 93Urinary Bladder Neoplasms 90Sarcoma 90Glioma 88Lymphoma, Large B-Cell, Diffuse 81Small Cell Lung Carcinoma 80

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Hepatocellular Carcinoma Resectable × 90 days × Clear all
NCT06157060 2026-03-20

Prediction of Hepatocellular Carcinoma Recurrence After Curative Treatment by Longitudinal Monitoring MRD Based on ctDNA

Zhujiang Hospital

Recruiting
255 enrolled
Gastrointestinal

Hepatocellular Carcinoma Resectable

Data powered by HemOnc (CC BY 4.0) Colophon âš¡